Skip to main content
. 2020 Mar 19;28(5):550–559. doi: 10.1016/j.jsps.2020.03.006

Fig. 4.

Fig. 4

Inhibition of HBeAg expressions by quercetin, myricetin-3-O-rhamnoside, and lamivudine relative to untreated control in HepG2.2.2.15 culture supernatants at day 1, 3 and 5 post-treatment. Values on Y-axis are means of three determinations (*P < 0.05, **P < 0.01, ***P < 0.001).